The business aims to increase its financial commitment in biotechnology and biosimilars, focusing on an approximate market price of USD twenty five billion in India by 2025. Wockhardt's attempts to scale up production capabilities are evident, with ideas to enhance output potential by 30% around the next two a long https://socialioapp.com/story4843996/the-best-side-of-wockhardt